Pothier, Kristell
,
Saint-Aubert, Laure
Hooper, Claudie
Delrieu, Julien
Payoux, Pierre
de Souto Barreto, Philipe
Vellas, Bruno
Funding for this research was provided by:
French Ministry of Health (PHRC 2008)
Institut de Recherche Pierre Fabre
Avid radiopharmaceuticals Eli Lilly and Company
Article History
Received: 3 August 2018
Revised: 5 December 2018
Accepted: 18 January 2019
First Online: 28 January 2019
Compliance with ethical standards
:
: Prof. P. Payoux served on the scientific advisory board of Avid Radiopharmaceuticals and GEHC. Dr. J. Delrieu served on the scientific advisory board of Avid Radiopharmaceuticals. Prof. B. Vellas served on the scientific advisory board of Avid Radiopharmaceuticals. Other authors (Dr K. Pothier, Dr L. Saint-Aubert, Dr C. Hooper, Dr de Souto Baretto) declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.